Insulin sparing action of Adenovirus 36 and its E4orf1 protein

Journal of Diabetes and its Complications

Volumn 27, Issue 2, 2013, Pages 191-199

  Dhurandhar, Nikhil V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Ad36; Adenovirus; Adenovirus 36; Adipogenesis; Adiposity; Anti diabetic; E4orf1; Glycemic control; Obesity

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; PROTEIN E4ORF1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ADENOVIRUS 36; ADENOVIRUS INFECTION; ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; CELL METABOLISM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FATTY LIVER; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; LIVER CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TISSUE EXPANSION; UPREGULATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG DESIGN; DRUG MONITORING; DRUG SYNERGISM; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ONCOGENE PROTEINS, VIRAL;

EID: 84875218834     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.09.006     Document Type: Review

References (96)

1. L.J. Appel, J.M. Clark, H.C. Yeh, N.Y. Wang, J.W. Coughlin, G. Daumit, E.R. Miller 3rd, A. Dalcin, G.J. Jerome, S. Geller, G. Noronha, T. Pozefsky, J. Charleston, J.B. Reynolds, N. Durkin, R.R. Rubin, T.A. Louis, and F.L. Brancati Comparative effectiveness of weight-loss interventions in clinical practice The New England Journal of Medicine 365 2011 1959 1968
2. P. Arner, E. Arner, A. Hammarstedt, and U. Smith Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis PLoS One 6 2011 e18284
3. R.L. Atkinson, N.V. Dhurandhar, D.B. Allison, R.L. Bowen, B.A. Israel, J.B. Albu, and A.S. Augustus Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids International Journal of Obesity 29 2005 281 286
4. M. Benito, A. Porras, A.R. Nebreda, and E. Santos Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes Science 253 1991 565 568
5. E. Bugianesi, A. Gastaldelli, E. Vanni, R. Gambino, M. Cassader, S. Baldi, V. Ponti, G. Pagano, E. Ferrannini, and M. Rizzetto Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms Diabetologia 48 2005 634 642
6. J. Capeau, J. Magre, O. Lascols, M. Caron, V. Bereziat, C. Vigouroux, and J.P. Bastard Diseases of adipose tissue: Genetic and acquired lipodystrophies Biochemical Society Transactions 33 2005 1073 1077
7. S.H. Chung, K.K. Frese, R.S. Weiss, B.V. Prasad, and R.T. Javier A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles Journal of Virology 81 2007 4787 4797
8. N.V. Dhurandhar A framework for identification of infections that contribute to human obesity The Lancet Infectious Diseases 11 2011 963 969
9. E.J. Dhurandhar, C. Dong, J. Ye, and N.V. Dhurandhar Ad36 E4orf1: A novel ligand to attenuate hepatic steatosis without weight loss? Obesity 19 2011 S86
10. E.J. Dhurandhar, O. Dubuisson, N. Mashtalir, R. Krishnapuram, V. Hegde, and N.V. Dhurandhar E4orf1: A novel ligand that improves glucose disposal in cell culture PLoS One 6 8 2011 e23394
11. E.J. Dhurandhar, R. Krishnapuram, V. Hegde, O. Dubuisson, R. Tao, X.C. Dong, J. Ye, and N.V. Dhurandhar E4orf1 Improves Lipid and Glucose Metabolism in Hepatocytes: A Template to Improve Steatosis & Hyperglycemia PLoS ONE 7 10 2012 e47813 http://dx.doi.org/10.1371/journal.pone.0047813
12. N.V. Dhurandhar, B.A. Israel, J.M. Kolesar, G.F. Mayhew, M.E. Cook, and R.L. Atkinson Increased adiposity in animals due to a human virus International Journal of Obesity and Related Metabolic Disorders 24 2000 989 996
13. N.V. Dhurandhar, B.A. Israel, J.M. Kolesar, G. Mayhew, M.E. Cook, and R.L. Atkinson Transmissibility of adenovirus-induced adiposity in a chicken model International Journal of Obesity and Related Metabolic Disorders 25 2001 990 996
14. N. Dhurandhar, P. Kulkarni, S. Ajinkya, and A. Sherikar Avian adenovirus leading to pathognomonic obesity in chicken Journal of Bombay Vetrinary College. 2 1990 131 132
15. N.V. Dhurandhar, P. Kulkarni, S.M. Ajinkya, and A. Sherikar Effect of adenovirus infection on adiposity in chicken Veterinary Microbiology 31 1992 101 107
16. N.V. Dhurandhar, P.R. Kulkarni, S.M. Ajinkya, A.A. Sherikar, and R.L. Atkinson Association of adenovirus infection with human obesity Obesity Research 5 1997 464 469
17. N.V. Dhurandhar, L.D. Whigham, D.H. Abbott, N.J. Schultz-Darken, B.A. Israel, S.M. Bradley, J.W. Kemnitz, D.B. Allison, and R.L. Atkinson Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys The Journal of Nutrition 132 2002 3155 3160
18. J. Dorrestijn, D.M. Ouwens, N. Van den Berghe, J.L. Bos, and J.A. Maassen Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin Diabetologia 39 1996 558 563
19. O. Dubuisson, E.J. Dhurandhar, R. Krishnapuram, H. Kirk-Ballard, A.K. Gupta, V. Hegde, E. Floyd, J.M. Gimble, and N.V. Dhurandhar PPAR{gamma}- independent increase in glucose uptake and adiponectin abundance in fat cells Endocrinology 2011
20. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumrad, B.W. Patterson, A. Okunade, and S. Klein Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proceedings of the National Academy of Sciences of the United States of America 106 2009 15430 15435
21. Fabbrini, E., Sullivan, S. and Klein, S., Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51, 679-89.
22. C. Fernandes-Santos, R.E. Carneiro, L. de Souza Mendonca, M.B. Aguila, and C.A. Mandarim-de-Lacerda Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet Nutrition 25 2009 818 827
23. C. Fernandes-Santos, R. Evangelista Carneiro, L. de Souza Mendonca, M. Barbosa Aguila, and C.A. Mandarim-de-Lacerda Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet Pancreas 38 2009 e80 e86
24. C.A. Finlay, P.W. Hinds, and A.J. Levine The p53 proto-oncogene can act as a suppressor of transformation Cell 57 1989 1083 1093
25. H.M. Foy, and J.T. Grayston S. Evans Alfred, Adenoviruses, "viral infections of humans: Epidemiology and control" 1976 Plenum Medical New York 53 70
26. K.K. Frese, I.J. Latorre, S.H. Chung, G. Caruana, A. Bernstein, S.N. Jones, L.A. Donehower, M.J. Justice, C.C. Garner, and R.T. Javier Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor The EMBO Journal 25 2006 1406 1417
27. K.K. Frese, S.S. Lee, D.L. Thomas, I.J. Latorre, R.S. Weiss, B.A. Glaunsinger, and R.T. Javier Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein Oncogene 22 2003 710 721
28. A. Garg Lipodystrophies The American Journal of Medicine 108 2000 143 152
29. L.J. Goodyear, F. Giorgino, L.A. Sherman, J. Carey, R.J. Smith, and G.L. Dohm Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects The Journal of Clinical Investigation 95 1995 2195 2204
30. Z.A. Habib, S.L. Havstad, K. Wells, G. Divine, M. Pladevall, and L.K. Williams Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus The Journal of Clinical Endocrinology and Metabolism 95 2010 592 600
31. J.C. Hierholzer, R. Wigand, L.J. Anderson, T. Adrian, and J.W. Gold Adenoviruses from patients with AIDS: A plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47) The Journal of Infectious Diseases 158 1988 804 813
32. J. Horvath, L. Palkonyay, and J. Weber Group C adenovirus DNA sequences in human lymphoid cells Journal of Virology 59 1986 189 192
33. K.L. Houseknecht, A.X. Zhu, L. Gnudi, A. Hamann, J.R. Zierath, E. Tozzo, J.S. Flier, and B.B. Kahn Overexpression of Ha-ras selectively in adipose tissue of transgenic mice. Evidence for enhanced sensitivity to insulin The Journal of Biological Chemistry 271 1996 11347 11355
34. Z.Y. Jiang, Q.L. Zhou, K.A. Coleman, M. Chouinard, Q. Boese, and M.P. Czech Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing Proceedings of the National Academy of Sciences of the United States of America 100 2003 7569 7574
35. T. Khan, E.S. Muise, P. Iyengar, Z.V. Wang, M. Chandalia, N. Abate, B.B. Zhang, P. Bonaldo, S. Chua, and P.E. Scherer Metabolic dysregulation and adipose tissue fibrosis: Role of collagen VI Molecular and Cellular Biology 29 2009 1575 1591
36. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, G. Li, L.A. Jelicks, M.F. Mehler, D.Y. Hui, Y. Deshaies, G.I. Shulman, G.J. Schwartz, and P.E. Scherer Obesity-associated improvements in metabolic profile through expansion of adipose tissue The Journal of Clinical Investigation 117 2007 2621 2637
37. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375
38. A. Kotronen, H. Yki-Jarvinen, K. Sevastianova, R. Bergholm, A. Hakkarainen, K.H. Pietilainen, L. Juurinen, N. Lundbom, and T.I. Sorensen Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome Obesity 19 2011 23 28
39. L. Kozma, K. Baltensperger, J. Klarlund, A. Porras, E. Santos, and M.P. Czech The ras signaling pathway mimics insulin action on glucose transporter translocation Proceedings of the National Academy of Sciences of the United States of America 90 1993 4460 4464
40. R. Krishnapuram, E.J. Dhurandhar, O. Dubuisson, H. Kirk-Ballard, S. Bajpeyi, N.F. Butte, M.S. Sothern, E. Larsen-Meyer, S. Chalew, B. Bennett, A.K. Gupta, F.L. Greenway, W.D. Johnson, M. Brashear, G. Reinhart, T. Rankinen, C. Bouchard, W.T. Cefalu, J. Ye, R. Javier, A. Zuberi, and N.V. Dhurandhar A template to improve glycemic control without reducing adiposity or dietary fat American Journal of Physiology. Endocrinology and Metabolism 300 2011 E779 E789
41. Krishnapuram, R., Kirk-Ballard, H., Dhurandhar, E.J., Dubuisson, O., Messier, V., Rabasa-Lhoret, R., Hegde, V., Aggarwal, S. and NV, D., 2012. Insulin receptor-independent up-regulation of cellular glucose uptake. International Journal of Obesity. In press.
42. N. Kubota, T. Yamauchi, K. Tobe, and T. Kadowaki Adiponectin dependent and independent pathways in insulin sensitizing and anti diabetic actions of thiazolidinediones Diabetes 55 2006 S32 S38
43. O. Kuda, B. Stankova, E. Tvrzicka, M. Hensler, T. Jelenik, M. Rossmeisl, P. Flachs, and J. Kopecky Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet Journal of Physiology and Pharmacology 60 2009 135 140
44. P. Lang, V. van Harmelen, M. Ryden, M. Kaaman, P. Parini, C. Carneheim, A.I. Cassady, D.A. Hume, G. Andersson, and P. Arner Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity PLoS One 3 2008 e1713
45. T.M. Larsen, S. Toubro, and A. Astrup PPARgamma agonists in the treatment of type II diabetes: Is increased fatness commensurate with long-term efficacy? International Journal of Obesity and Related Metabolic Disorders 27 2003 147 161
46. I.J. Latorre, M.H. Roh, K.K. Frese, R.S. Weiss, B. Margolis, and R.T. Javier Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells Journal of Cell Science 118 2005 4283 4293
47. L.L. Lipscombe, T. Gomes, L.E. Levesque, J.E. Hux, D.N. Juurlink, and D.A. Alter Thiazolidinediones and cardiovascular outcomes in older patients with diabetes JAMA: The Journal of the American Medical Association 298 2007 2634 2643
48. G. Lutchman, K. Promrat, D.E. Kleiner, T. Heller, M.G. Ghany, J.A. Yanovski, T.J. Liang, and J.H. Hoofnagle Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: Relationship to histological improvement Clinical Gastroenterology and Hepatology 4 2006 1048 1052
49. H.N. Na, and J.H. Nam Adenovirus 36 as an obesity agent maintains the obesity state by Increasing MCP-1 and inducing inflammation The Journal of Infectious Diseases 205 2012 914 922
50. A.R. Nawrocki, M.W. Rajala, E. Tomas, U.B. Pajvani, A.K. Saha, M.E. Trumbauer, Z. Pang, A.S. Chen, N.B. Ruderman, H. Chen, L. Rossetti, and P.E. Scherer Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists The Journal of Biological Chemistry 281 2006 2654 2660
51. R. Neumann, E. Genersch, and H.J. Eggers Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus Virus Research 7 1987 93 97
52. M.J. Pagliassotti, J. Kang, J.S. Thresher, C.K. Sung, and M.E. Bizeau Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance American Journal of Physiology. Endocrinology and Metabolism 282 2002 E170 E176
53. M. Pasarica, S. Loiler, and N.V. Dhurandhar Acute effect of infection by adipogenic human adenovirus Ad36 Archives of Virology 153 11 2008 2097 2102
54. M. Pasarica, N. Mashtalir, E.J. McAllister, G.E. Kilroy, J. Koska, P. Permana, B. de Courten, M. Yu, E. Ravussin, J.M. Gimble, and N.V. Dhurandhar Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells Stem Cells 26 2008 969 978
55. M. Pasarica, A.C. Shin, M. Yu, H.M. Ou Yang, M. Rathod, K.L. Jen, S. MohanKumar, P.S. MohanKumar, N. Markward, and N.V. Dhurandhar Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats Obesity (Silver Spring) 14 2006 1905 1913
56. H.G. Pereira, R.J. Huebner, H.S. Ginsberg, and J. Van Der Veen A short description of the adenovirus group Virology 20 1963 613 620
57. J.E. Pessin, and A.R. Saltiel Signaling pathways in insulin action: Molecular targets of insulin resistance The Journal of Clinical Investigation 106 2000 165 169
58. M.E. Ramos-Nino, C.D. MacLean, and B. Littenberg Association between cancer prevalence and use of thiazolidinediones: Results from the Vermont Diabetes Information System BMC Medicine 5 2007 17
59. M. Rathod, P.M. Rogers, S.D. Vangipuram, E.J. McAllister, and N.V. Dhurandhar Adipogenic cascade can be induced without adipogenic media by a human adenovirus Obesity 17 2009 657 664
60. M.A. Rathod, P.M. Rogers, S.D. Vangipuram, E.J. McAllister, and N.V. Dhurandhar Adipogenic cascade can be induced without adipogenic media by a human adenovirus Obesity (Silver Spring) 17 2009 657 664
61. M. Rathod, S.D. Vangipuram, B. Krishnan, A.R. Heydari, T.C. Holland, and N.V. Dhurandhar Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes International Journal of Obesity 31 2007 78 86
62. P.M. Rogers, K.A. Fusinski, M.A. Rathod, S.A. Loiler, M. Pasarica, M.K. Shaw, G. Kilroy, G.M. Sutton, E.J. McAllister, N. Mashtalir, J.M. Gimble, T.C. Holland, and N.V. Dhurandhar Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene International Journal of Obesity 32 2008 397 406
63. P.M. Rogers, N. Mashtalir, M.A. Rathod, O. Dubuisson, Z. Wang, K. Dasuri, S. Babin, A. Gupta, N. Markward, W.T. Cefalu, and N.V. Dhurandhar Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36 Diabetes 57 2008 2321 2331
64. F.M. Sacks, G.A. Bray, V.J. Carey, S.R. Smith, D.H. Ryan, S.D. Anton, K. McManus, C.M. Champagne, L.M. Bishop, N. Laranjo, M.S. Leboff, J.C. Rood, L. de Jonge, F.L. Greenway, C.M. Loria, E. Obarzanek, and D.A. Williamson Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates The New England Journal of Medicine 360 2009 859 873
65. A.T. Sasaki, C. Chun, K. Takeda, and R.A. Firtel Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement The Journal of Cell Biology 167 2004 505 518
66. R.K. Semple, E.K. Cochran, M.A. Soos, K.A. Burling, D.B. Savage, P. Gorden, and S. O'Rahilly Plasma adiponectin as a marker of insulin receptor dysfunction: Clinical utility in severe insulin resistance Diabetes Care 31 2008 977 979
67. R.K. Semple, A. Sleigh, P.R. Murgatroyd, C.A. Adams, L. Bluck, S. Jackson, A. Vottero, D. Kanabar, V. Charlton-Menys, P. Durrington, M.A. Soos, T.A. Carpenter, D.J. Lomas, E.K. Cochran, P. Gorden, S. O'Rahilly, and D.B. Savage Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis The Journal of Clinical Investigation 119 2009 315 322
68. A. Seppala-Lindroos, S. Vehkavaara, A.M. Hakkinen, T. Goto, J. Westerbacka, A. Sovijarvi, J. Halavaara, and H. Yki-Jarvinen Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men The Journal of Clinical Endocrinology and Metabolism 87 2002 3023 3028
69. M. Serrano-Rios, N. Melchionda, and E. Moreno-Carretero Role of sibutramine in the treatment of obese type 2 diabetic patients receiving sulphonylurea therapy Diabetic Medicine: A Journal of the British Diabetic Association 19 2002 119 124
70. G. Sesti, M. Federici, M.L. Hribal, D. Lauro, P. Sbraccia, and R. Lauro Defects of the insulin receptor substrate (IRS) system in human metabolic disorders The FASEB Journal 15 2001 2099 2111
71. G. Sesti, M. Federici, D. Lauro, P. Sbraccia, and R. Lauro Molecular mechanism of insulin resistance in type 2 diabetes mellitus: Role of the insulin receptor variant forms Diabetes/Metabolism Research and Reviews 17 2001 363 373
72. R.J. Shaw, and L.C. Cantley Ras, PI(3)K and mTOR signalling controls tumour cell growth Nature 441 2006 424 430
73. Z. Shen, X. Liang, C.Q. Rogers, D. Rideout, and M. You Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice American Journal of Physiology. Gastrointestinal and Liver Physiology 298 2010 G364 G374
74. Y. Shen, and T.E. Shenk Viruses and apoptosis Current Opinion in Genetics and Development 5 1995 105 111
75. P.R. Shepherd, L. Gnudi, E. Tozzo, H. Yang, F. Leach, and B.B. Kahn Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue The Journal of Biological Chemistry 268 1993 22243 22246
76. C.D. Sjostrom, T. Lystig, and A.K. Lindroos Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study International Journal of Obesity 35 2011 1413 1420
77. P.W. So, A.H. Herlihy, and J.D. Bell Adiposity induced by adenovirus 5 inoculation International Journal of Obesity and Related Metabolic Disorders 29 2005 603 606
78. B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 2005 2460 2470
79. S. Suire, A.M. Condliffe, G.J. Ferguson, C.D. Ellson, H. Guillou, K. Davidson, H. Welch, J. Coadwell, M. Turner, E.R. Chilvers, P.T. Hawkins, and L. Stephens Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils Nature Cell Biology 8 2006 1303 1309
80. L.P. Svetkey, V.J. Stevens, P.J. Brantley, L.J. Appel, J.F. Hollis, C.M. Loria, W.M. Vollmer, C.M. Gullion, K. Funk, P. Smith, C. Samuel-Hodge, V. Myers, L.F. Lien, D. Laferriere, B. Kennedy, G.J. Jerome, F. Heinith, D.W. Harsha, P. Evans, T.P. Erlinger, A.T. Dalcin, J. Coughlin, J. Charleston, C.M. Champagne, A. Bauck, J.D. Ard, K. Aicher, and G. Weight Loss Maintenance Collaborative Research Comparison of strategies for sustaining weight loss: The weight loss maintenance randomized controlled trial JAMA: The Journal of the American Medical Association 299 2008 1139 1148
81. C.Y. Tan, and A. Vidal-Puig Adipose tissue expandability: The metabolic problems of obesity may arise from the inability to become more obese Biochemical Society Transactions 36 2008 935 940
82. G. Thomas, C.R., D. Tilkorn, E. Keramidaris, W. Morrison, A. Penington, and T. Blick Effect of human adenovirus-36 in a localized in vivo model of neoadipogenesis Obesity 16 2008 S74
83. M.K. Todd, M.J. Watt, J. Le, A.L. Hevener, and L.P. Turcotte Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance American Journal of Physiology. Endocrinology and Metabolism 292 2007 E485 E493
84. G.M. Trovato, A. Castro, A. Tonzuso, A. Garozzo, G.F. Martines, C. Pirri, F. Trovato, and D. Catalano Human obesity relationship with Ad36 adenovirus and insulin resistance International Journal of Obesity 33 2009 1402 1409
85. G.M. Trovato, G.F. Martines, A. Garozzo, A. Tonzuso, R. Timpanaro, C. Pirri, F.M. Trovato, and D. Catalano Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease Liver International 30 2010 184 190
86. M.E. Trujillo, U.B. Pajvani, and P.E. Scherer Apoptosis through targeted activation of caspase 8 ("ATTAC-mice"): Novel mouse models of inducible and reversible tissue ablation Cell Cycle 4 2005 1141 1145
87. F.H. van Tienen, C.J. van der Kallen, P.J. Lindsey, R.J. Wanders, M.M. van Greevenbroek, and H.J. Smeets Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity International Journal of Obesity 35 2011 1154 1164
88. S.D. Vangipuram, J. Sheele, R.L. Atkinson, T.C. Holland, and N.V. Dhurandhar A human adenovirus enhances preadipocyte differentiation Obesity Research 12 2004 770 777
89. S.D. Vangipuram, M. Yu, J. Tian, K.L. Stanhope, M. Pasarica, P.J. Havel, A.R. Heydari, and N.V. Dhurandhar Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells International Journal of Obesity 31 2007 87 96
90. G.L. Vega, M. Chandalia, L.S. Szczepaniak, and S.M. Grundy Metabolic correlates of nonalcoholic fatty liver in women and men Hepatology 46 2007 716 722
91. Z.Q. Wang, C.W., X.H. Zhang, Y. Yongmei, J. Qin, L. Son, P.M. Rogers, N. Mashtalir, J.R. Bordelon, J. Ye, and N.V. Dhurandhar Human adenovirus type 36 enhances glucose uptake in diabetic and non-diabetic human skeletal muscle cells independent of insulin signaling Diabetes 57 2008 1805 1813
92. L.D. Whigham, B.A. Israel, and R.L. Atkinson Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 2006 R190 R194
93. R. Wigand, H. Gelderblom, and G. Wadell New human adenovirus (candidate adenovirus 36), a novel member of subgroup D Archives of Virology 64 1980 225 233
94. G. Wronka, G. Bernardi, and W. Doerfler Localization of integrated adenovirus DNA in the hamster genome Cellular and Molecular Life Sciences 61 2004 2983 2990
95. J.M. Ye, N. Dzamko, M.E. Cleasby, B.D. Hegarty, S.M. Furler, G.J. Cooney, and E.W. Kraegen Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: Comparison with metformin Diabetologia 47 2004 1306 1313
96. C.W. Younce, A. Azfer, and P.E. Kolattukudy MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma The Journal of Biological Chemistry 284 2009 27620 27628